| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/JHEP.2000.9113 |
| P698 | PubMed publication ID | 10915725 |
| P2093 | author name string | Yoshida S | |
| Nakamura H | |||
| Murakami T | |||
| Kawata S | |||
| Monden M | |||
| Sakon M | |||
| Tokunaga K | |||
| Yonezawa T | |||
| Nishikawa M | |||
| Murata M | |||
| Imai Y | |||
| Shibata K | |||
| Wakasa K | |||
| Ohsawa M | |||
| Nagano H | |||
| Kurokawa M | |||
| Zushi S | |||
| Takamura M | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 205-212 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading | |
| P478 | volume | 32 |
| Q30479629 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma |
| Q53165025 | Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. |
| Q36326173 | Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. |
| Q30462259 | Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT |
| Q48204240 | Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades |
| Q36789118 | Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media |
| Q26823224 | Clinical utility of imaging for evaluation of hepatocellular carcinoma |
| Q37794906 | Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate‐ and ferucarbotran‐enhanced magnetic resonance imaging |
| Q30455788 | Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases |
| Q30488974 | Current role of ultrasound for the management of hepatocellular carcinoma |
| Q90319575 | Current role of ultrasound in the diagnosis of hepatocellular carcinoma |
| Q47921502 | Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging |
| Q53558298 | Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. |
| Q41881803 | Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma |
| Q36044414 | Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. |
| Q36348796 | Early liver cancer: concepts, diagnosis, and management |
| Q36179721 | Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions |
| Q35207733 | Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians |
| Q84274443 | Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow |
| Q46593010 | Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI. |
| Q34922580 | Imaging evaluation of hepatocellular carcinoma |
| Q30436747 | Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring |
| Q98177352 | Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis |
| Q78073632 | MR imaging of hepatocellular carcinoma |
| Q51652107 | MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. |
| Q37370018 | Multistep human hepatocarcinogenesis: correlation of imaging with pathology |
| Q34369626 | Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. |
| Q45364465 | New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography |
| Q36309174 | Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma |
| Q36324508 | Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI. |
| Q52099439 | Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography |
| Q34000035 | Quantitative evaluation of the reticuloendothelial system function with dynamic MRI |
| Q28533335 | Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer |
| Q35543614 | Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes |
| Q37118064 | SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings |
| Q56989774 | Small ( |
| Q88908890 | Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Imaging of Spontaneous Hepatic Neoplasia in a Cynomolgus Macaque (Macaca fascicularis) |
| Q52859764 | Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxides in patients with advanced disease. |
| Q24613744 | Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application |
| Q28082299 | Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis |
| Q79623587 | T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules |
| Q52036938 | Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. |
| Q83706741 | Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images |
| Q79196761 | Using Superparamagnetic Iron Oxide–Enhanced MRI to Differentiate Metastatic Hepatic Tumors and Nonsolid Benign Lesions |
| Q41698006 | Utility of Gd-EOB-DTPA-Enhanced MRI in Diagnosing Small Hepatocellular Carcinoma |
| Q53183597 | Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. |
Search more.